Autopsy report · NCT01812213
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
Cause of deathNo reason given
Life of this trial
- Ran for about 4 years 8 months before it stopped.
- 76 participants enrolled.
- Results were posted on the registry 6 years 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Navidea Biopharmaceuticals
- Sponsor type
- Industry
- Conditions
- Mild Cognitive Impairment
- Interventions
- [18F]NAV4694
- Participants
- 76
- Sites
- 11
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.